AxoGen's GAAP loss for 9M 2021 was $21.699 million, up 22.1% from $17.776 million in the previous year. Revenues increased 20.1% to $95.821 million from $79.805 million a year earlier.
AxoGen's GAAP loss for 9M 2021 was $21.699 million, up 22.1% from $17.776 million in the previous year. Revenues increased 20.1% to $95.821 million from $79.805 million a year earlier. 
ir.axogeninc.com
English (US) 